Westbourne Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
AAMU
Westbourne Investment Advisors's GILD Position: Q2 2019 in Review
Westbourne Investment Advisors sold out of Gilead Sciences (GILD) in Q2 2019, closing a stake of 5,685 shares — an estimated $370K sold.
Westbourne Investment Advisors first reported a position in GILD in Q2 2015 and held it in 16 quarters. The position peaked at $5.06M in Q2 2015. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.
- Westbourne Investment Advisors reported no remaining Gilead Sciences position as of Q2 2019 after selling out during the quarter.
- Westbourne Investment Advisors sold 5,685 Gilead Sciences shares in Q2 2019, an estimated $370K.
- Westbourne Investment Advisors first reported a position in Gilead Sciences in Q2 2015 and held it in 16 quarters.
- Westbourne Investment Advisors's Gilead Sciences position peaked at $5.06M in Q2 2015.
- 1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.
Based on Westbourne Investment Advisors's 13F filing for Q2 2019, filed 22 Jul 2019.